Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,276
archived clinical trials in
Pancreatic Cancer

Dose Escalation Study MORAb-066 Targeting TF-expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC
A Phase I Study of the Safety, Tolerability, and PK of MORAb-066, a Humanized Monoclonal Antibody to Human TF, in Patients With Advanced or Metastatic Breast, Pancreatic, Colorectal, or NSCLC (Adenocarcinoma) Malignancies
Status: Enrolling
Updated:  4/15/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Dose Escalation Study MORAb-066 Targeting TF-expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC
A Phase I Study of the Safety, Tolerability, and PK of MORAb-066, a Humanized Monoclonal Antibody to Human TF, in Patients With Advanced or Metastatic Breast, Pancreatic, Colorectal, or NSCLC (Adenocarcinoma) Malignancies
Status: Enrolling
Updated: 4/15/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Dose Escalation Study MORAb-066 Targeting TF-expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC
A Phase I Study of the Safety, Tolerability, and PK of MORAb-066, a Humanized Monoclonal Antibody to Human TF, in Patients With Advanced or Metastatic Breast, Pancreatic, Colorectal, or NSCLC (Adenocarcinoma) Malignancies
Status: Enrolling
Updated:  4/15/2016
Clinical Research Facility
mi
from
Nashville, TN
Dose Escalation Study MORAb-066 Targeting TF-expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC
A Phase I Study of the Safety, Tolerability, and PK of MORAb-066, a Humanized Monoclonal Antibody to Human TF, in Patients With Advanced or Metastatic Breast, Pancreatic, Colorectal, or NSCLC (Adenocarcinoma) Malignancies
Status: Enrolling
Updated: 4/15/2016
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor Response
A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor Response
Status: Enrolling
Updated:  6/2/2016
University of Michigan Cancer Center
mi
from
Ann Arbor, MI
A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor Response
A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor Response
Status: Enrolling
Updated: 6/2/2016
University of Michigan Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Fatigue and Pancreas and Bile Duct Cancer Study
Fatigue, Physical Functioning, and Quality of Life in Patients With Pancreatic and Periampullary Cancers Following Surgery, Chemotherapy, and/or Radiation Therapy
Status: Enrolling
Updated:  6/6/2016
Thomas Jefferson University
mi
from
Philadelphia, PA
Fatigue and Pancreas and Bile Duct Cancer Study
Fatigue, Physical Functioning, and Quality of Life in Patients With Pancreatic and Periampullary Cancers Following Surgery, Chemotherapy, and/or Radiation Therapy
Status: Enrolling
Updated: 6/6/2016
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy
Smoking Relapse Prevention Among Postpartum Women
Status: Enrolling
Updated:  6/27/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy
Smoking Relapse Prevention Among Postpartum Women
Status: Enrolling
Updated: 6/27/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Gemcitabine and CT-011 for Resected Pancreatic Cancer
A Pilot Study to Test the Feasibility of the Combination of Gemcitabine and Anti-PD1 Monoclonal Antibody (CT-011) in the Treatment of Resected Pancreatic Cancer
Status: Enrolling
Updated:  6/28/2016
Augusta University
mi
from
Augusta, GA
Gemcitabine and CT-011 for Resected Pancreatic Cancer
A Pilot Study to Test the Feasibility of the Combination of Gemcitabine and Anti-PD1 Monoclonal Antibody (CT-011) in the Treatment of Resected Pancreatic Cancer
Status: Enrolling
Updated: 6/28/2016
Augusta University
mi
from
Augusta, GA
Click here to add this to my saved trials
Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer
Phase Ib Trial of Gemcitabine and Oxaliplatin (GEMOX) With Erlotinib in Patients With Advanced Biliary Tract Cancer.
Status: Enrolling
Updated:  6/28/2016
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer
Phase Ib Trial of Gemcitabine and Oxaliplatin (GEMOX) With Erlotinib in Patients With Advanced Biliary Tract Cancer.
Status: Enrolling
Updated: 6/28/2016
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer
Phase Ib Trial of Gemcitabine and Oxaliplatin (GEMOX) With Erlotinib in Patients With Advanced Biliary Tract Cancer.
Status: Enrolling
Updated:  6/28/2016
Vanderbilt-Ingram Cancer Center - Cool Springs
mi
from
Nashville, TN
Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer
Phase Ib Trial of Gemcitabine and Oxaliplatin (GEMOX) With Erlotinib in Patients With Advanced Biliary Tract Cancer.
Status: Enrolling
Updated: 6/28/2016
Vanderbilt-Ingram Cancer Center - Cool Springs
mi
from
Nashville, TN
Click here to add this to my saved trials
Relationship Between Vitamin D Biomarkers and Survival in Blood Samples From Patients With Advanced Pancreatic Cancer
The Relationship of Serum 25-Hydroxyvitamin D to Overall Survival in Advanced Pancreatic Cancer
Status: Enrolling
Updated:  6/28/2016
Charles R. Wood Cancer Center at Glens Falls Hospital
mi
from
Glens Falls, NY
Relationship Between Vitamin D Biomarkers and Survival in Blood Samples From Patients With Advanced Pancreatic Cancer
The Relationship of Serum 25-Hydroxyvitamin D to Overall Survival in Advanced Pancreatic Cancer
Status: Enrolling
Updated: 6/28/2016
Charles R. Wood Cancer Center at Glens Falls Hospital
mi
from
Glens Falls, NY
Click here to add this to my saved trials
Prognostic Value of Baseline Computed Tomography (CT) Perfusion Parameters of Pancreatic Cancer for Patients Undergoing Stereotactic Body Radiotherapy or Surgical Resection
Prognostic Value of Baseline CT Perfusion Parameters of Pancreatic Cancer for Patients Undergoing Stereotactic Body Radiotherapy or Surgical Resection
Status: Enrolling
Updated:  6/30/2016
Stanford University School of Medicine
mi
from
Stanford, CA
Prognostic Value of Baseline Computed Tomography (CT) Perfusion Parameters of Pancreatic Cancer for Patients Undergoing Stereotactic Body Radiotherapy or Surgical Resection
Prognostic Value of Baseline CT Perfusion Parameters of Pancreatic Cancer for Patients Undergoing Stereotactic Body Radiotherapy or Surgical Resection
Status: Enrolling
Updated: 6/30/2016
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Veterans Affairs Medical Center - Birmingham
mi
from
Birmingham, AL
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Veterans Affairs Medical Center - Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
University of California San Diego Cancer Center
mi
from
La Jolla, CA
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
University of California San Diego Cancer Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
UCSF Cancer Center and Cancer Research Institute
mi
from
San Francisco, CA
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
UCSF Cancer Center and Cancer Research Institute
mi
from
San Francisco, CA
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Veterans Affairs Medical Center - San Francisco
mi
from
San Francisco, CA
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Veterans Affairs Medical Center - San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
CCOP - Christiana Care Health Services
mi
from
Wilmington, DE
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
CCOP - Christiana Care Health Services
mi
from
Wilmington, DE
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Vincent T. Lombardi Cancer Research Center, Georgetown University
mi
from
Washington,
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Vincent T. Lombardi Cancer Research Center, Georgetown University
mi
from
Washington,
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Walter Reed Army Medical Center
mi
from
Washington,
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Walter Reed Army Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Mount Sinai Medical Center CCOP
mi
from
Miami Beach, FL
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Mount Sinai Medical Center CCOP
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
University of Illinois at Chicago Health Sciences Center
mi
from
Chicago, IL
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
University of Illinois at Chicago Health Sciences Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Veterans Affairs Medical Center - Chicago Westside Hospital
mi
from
Chicago, IL
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Veterans Affairs Medical Center - Chicago Westside Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
University of Chicago Cancer Research Center
mi
from
Chicago, IL
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
University of Chicago Cancer Research Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Veterans Affairs Medical Center - Togus
mi
from
Togus, ME
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Veterans Affairs Medical Center - Togus
mi
from
Togus, ME
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Marlene & Stewart Greenebaum Cancer Center, University of Maryland
mi
from
Baltimore, MD
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Marlene & Stewart Greenebaum Cancer Center, University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Massachusetts General Hospital Cancer Center
mi
from
Boston, MA
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Massachusetts General Hospital Cancer Center
mi
from
Boston, MA
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Dana-Farber Cancer Institute
mi
from
Boston, MA
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
University of Massachusetts Memorial Medical Center
mi
from
Worcester, MA
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
University of Massachusetts Memorial Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Veterans Affairs Medical Center - Minneapolis
mi
from
Minneapolis, MN
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Veterans Affairs Medical Center - Minneapolis
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Veterans Affairs Medical Center - Columbia (Truman Memorial)
mi
from
Columbia, MO
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Veterans Affairs Medical Center - Columbia (Truman Memorial)
mi
from
Columbia, MO
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Ellis Fischel Cancer Center - Columbia
mi
from
Columbia, MO
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Ellis Fischel Cancer Center - Columbia
mi
from
Columbia, MO
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Veterans Affairs Medical Center - Omaha
mi
from
Omaha, NE
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Veterans Affairs Medical Center - Omaha
mi
from
Omaha, NE
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
CCOP - Southern Nevada Cancer Research Foundation
mi
from
Las Vegas, NV
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
CCOP - Southern Nevada Cancer Research Foundation
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Norris Cotton Cancer Center
mi
from
Lebanon, NH
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Norris Cotton Cancer Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Veterans Affairs Medical Center - Buffalo
mi
from
Buffalo, NY
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Veterans Affairs Medical Center - Buffalo
mi
from
Buffalo, NY
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
CCOP - North Shore University Hospital
mi
from
Manhasset, NY
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
CCOP - North Shore University Hospital
mi
from
Manhasset, NY
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
North Shore University Hospital
mi
from
Manhasset, NY
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
North Shore University Hospital
mi
from
Manhasset, NY
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
The New York Presbyterian Hospital - Cornell Campus
mi
from
New York, NY
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
The New York Presbyterian Hospital - Cornell Campus
mi
from
New York, NY
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Mount Sinai Medical Center, NY
mi
from
New York, NY
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Mount Sinai Medical Center, NY
mi
from
New York, NY
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C.
mi
from
Syracuse, NY
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C.
mi
from
Syracuse, NY
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
State University of New York Upstate Medical University
mi
from
Syracuse, NY
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
State University of New York Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Veterans Affairs Medical Center - Syracuse
mi
from
Syracuse, NY
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Veterans Affairs Medical Center - Syracuse
mi
from
Syracuse, NY
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Lineberger Comprehensive Cancer Center, UNC
mi
from
Chapel Hill, NC
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Lineberger Comprehensive Cancer Center, UNC
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Veterans Affairs Medical Center - Durham
mi
from
Durham, NC
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Veterans Affairs Medical Center - Durham
mi
from
Durham, NC
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Duke Comprehensive Cancer Center
mi
from
Durham, NC
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Duke Comprehensive Cancer Center
mi
from
Durham, NC
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
CCOP - Southeast Cancer Control Consortium
mi
from
Winston-Salem, NC
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
CCOP - Southeast Cancer Control Consortium
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Comprehensive Cancer Center of Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Comprehensive Cancer Center of Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated:  7/19/2016
Arthur G. James Cancer Hospital - Ohio State University
mi
from
Columbus, OH
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase II Chemoradiation Trial Using Gemcitabine in Patients With Locoregional Adenocarcinoma of the Pancreas
Status: Enrolling
Updated: 7/19/2016
Arthur G. James Cancer Hospital - Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials